Could cause temporary or reversible harm; serious harm is unlikely.
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
| Brand name | TACROLIMUS |
| Generic name | TACROLIMUS |
| Active ingredient(s) | TACROLIMUS |
| Distributed by / for | Sandoz Incorporated |
| NDC | 0781-2102-01 |
| Full product label | Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01 |
| Recalling firm | Sandoz Incorporated |
| Distribution | Nationwide |
| Quantity | 12,521 bottles |
| Recall initiated | 2013-10-22 |
| Report date | 2014-01-01 |
| Recall completed | 2014-07-10 |
| Recall number | D-383-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Broomfield CO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗